J. Antonio G Lopez MD FACC,FAHA,FACP,FNLA,FASH,FASPC,FRSM

Echocardiography, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation, Cardiac Critical Care

Clinical Research Medical Director Cardiovascular and Metabolic Therapeutic Area Global Development Amgen

One Amgen Center Drive27-3-ANewbury Park, CA 91320
Phone+1 820-222-4687

Dr. Lopez is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lopez's full profile Already have an account?

Summary

J. Antonio G. López, MD, FACC, FAHA, FACP, FACA, FCCP, FASE, FASA, FNLA, FASH, FASPC, FRSM, is Clinical Research Medical Director, Cardiovascular and Metabolic Therapeutic Area, Global Development at Amgen. He was most recently Cardiovascular Medical Director US Medical Organization and US Medical Organization CV Medical Advocacy Relations Lead at Amgen. He is a cardiologist, lipidologist, and hypertension specialist. Prior to joining Amgen in 2014, he was with Saint Alphonsus Medical Group Heart Care in Boise, Idaho. Dr. López was Director of Preventive Cardiology and CV Rehabilitation, Director of the Lipid Clinic, and Director of the LDL Apheresis Program at Saint Alphonsus Regional Medical Center in Boise, Idaho. He also served as Chair of Cardiology at Saint Alphonsus. In addition, he was Chair of CV Research and Education, Director of the Hypertension Consultation Service, and Director of the Carotid Intima-Media Thickness (CIMT) Program at Saint Alphonsus Medical Group Heart Care. His previous experience includes serving as Director of the Lipid Clinic and Director of CV Outpatient and Outreach Programs at the University of Iowa and Director of Cardiac Care and the Coronary Care Unit at the VA Medical Center in Iowa City, Iowa. He was also the Medical Director of Preventive Cardiology, CV Rehabilitation, the Lipid Clinic, and Prevention Center at the Prairie Heart Institute in Springfield, Illinois.
Dr. López received his medical degree Cum Laude from Harvard Medical School. He received the Henry J. Kaiser Family Foundation Merit Scholar Award at Harvard. He completed his residency in internal medicine at Cedars-Sinai Medical Center at the University of California, Los Angeles. He was a Research Fellow in the cardiac unit at the Massachusetts General Hospital. He completed a fellowship in cardiovascular diseases and interventional cardiology in the Department of Internal Medicine at the University of Iowa Hospitals and Clinics in Iowa City.

Education & Training

U Iowa Hosps and Clinics1986 - 1989
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1983 - 1986
Harvard Medical SchoolClass of 1983
Massachusetts General HospitalFellowship, Cardiac Unit, 1980 - 1981
University of California at San DiegoB.A, General Biology, Cum Laude, 1973 - 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1985 - 2027
ID State Medical License 2007 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Physician of the Year, Hispanic Health Leadership Award National Hispanic Medical Association (NHMA), 2018
Cardiovascular Medicine Distinguished Alumnus Award Division of Cardiovascular Medicine, The University of Iowa, 2018
Distinguished Alumnus Award for Achievement University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2018

Publications & Presentations

PubMed

Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER.
Yu Mi Kang, Robert P Giugliano, Anthony C Keech, J Antonio G López, Maria Laura Monsalvo
Journal of the American College of Cardiology. 2026-06-02
Lp(a) Has Specific Effects on Coronary Artery Disease Independent of LDL-C: A Mendelian Randomization Study.
Moa P Lee, Sarah H Koenigsberg, Mohammad Y Anwar, Laura M Raffield, Zhaotong Lin
JACC. Advances. 2026-05-01
6 citations
Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos.
Alexandrina Danilov, Priscilla Duran-Luciano, Yawen Yuan, Diana De Oliveira Gomes, J Antonio G López
Journal of the American College of Cardiology. 2025-12-09

Journal Articles

Obesity-Associated Cardiovascular Risk and Benefit from PCSK9 Inhibition: A Prespecified Analysis from FOURIER
Kang, Y.M., Giugliano, R.P., Keech, A.C., López, J.A.G., Monsalvo, M.L., Ohman, E.M., Ran, X., Murphy, S.A., Sabatine, M.S., and O’Donoghue, M.L., J Am Coll Cardiol. 2025: https://www.jacc.org/doi/10.1016/j.jacc.2025.10.036, 12/10/2025
Association of Lp(a) Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos
Danilov, A., Luciano, P.D., Yuan, Y., Gomes, D.D., López, J.A.G., Kent, S., Booth, J.N. III, Slipczuk, L., Martinez, C., Kaplan, R., Sotres-Alvarez, D., Thyagarajan, B..., J Am Coll Cardiol. 2025;86:2292–2310, 12/1/2025
Effects of Small-Interfering RNA Olpasiran on Apolipoprotein B Particles
Zimerman, A., López, J.A.G., Rosenson, R.S., Gaudet, D., Baum, S.J., Park, J-G., Wang, J., Wang, H., Wu, Y., Kassahun, H., Sabatine, M.S., and O’Donoghue, M.L., JAMA Cardiol. 2025;10;(12):1322-1324, 11/5/2025

Books/Book Chapters

Da La Mano A Tu Hermano.
Chapter: We Need Chicano Health Professionals
Page 1 - 2Lopez, J.A.: El ProblemaNational Chicano Health Organization, Harvard Medical School, Boston
Pathobiology of the Human Atherosclerotic Plaque.
Chapter: Hemodynamic Consequences of Changes in the Artery Wall During Atherogenesis
Page 481 - 496Lopez, J.A., Harrison, D.G., Armstrong, M.L., and Heistad, D.DEditors: S. Glagov, W.P. Newmann III, and S.A. Schaffer.Springer-Verlag New York, New York
Cardiovascular Clinics:Preventive Aspects of Coronary Heart Disease.
Chapter: Reversibility of Atherosclerosis
Page 113 - 126Armstrong, M.L., Heistad, D.D., Megan, M.D., Lopez, J.A.G., and Harrison, D.GEditors: E.D. Frohlich.F.A. Davis Company, Philadelphia

Abstracts/Posters

Activation of Leukocytes Constricts Large Cerebral Arteries in Atherosclerotic Monkeys.
Heistad, D.D., Faraci, F.M., Lopez, J.A.G., and Armstrong, M.L, J. Cereb. Blood Flow Metab
Coronary Sinus Endothelin Levels Rise After Coronary Balloon Angioplasty.
Kadel, K.A., Lopez, J.A.G., Rossen, J.D., Winniford, M.D., Talman, C.L., and Revtyak, G.R, Circulation
Effect of Intravascular Complement C5a in Atherosclerotic Primates.
Lopez, J.A.G., Mugge, A., Densen, P., Piegors, D.J., and Heistad, D.D, Circulation

Lectures

Neurogenic Vasoactive Properties of Ouabain.
Multiple locations, 1982, 1983
Nonbacterial Thrombotic Endocarditis: An Echocardiographic-pathologic Correlation.
American College of Physicians, Associates Program, Southern California Regions I, II, III and Hawai
Responsiveness of Iliac Collateral Vessels to Vasoconstrictor Stimuli in Atherosclerotic Primates.
Multiple locations